^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Rectal Cancer
    Regimen:FOLFIRI (irinotecan + leucovorin calcium + 5-fluorouracil)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    01/30/2020
    Excerpt:
    CAMPTOSAR is a topoisomerase inhibitor indicated for...First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum.
    Evidence Level:
    Sensitive: A2 - Guideline
    Source:
    NCCN
    Published date:
    12/20/2020
    Excerpt:
    Rectal cancer:.Primary treatment…FOLFORI or FOLFOX...